An eye drop manufacturer has announced a voluntary recall of certain dry eye drops after an audit from the U.S. Food and Drug Administration found “manufacturing cGMP deviations,” and has advised that consumers “immediately cease” use of the drops.
The product recall effects five different dry eye drop products manufactured by AvKARE that were sold between May 2023 and April 2025.
The Tennessee-based pharmaceutical company said the audit found deviations from the current regulation standards, known as Current Good Manufacturing Practice regulations.
However, the recall is out of precaution as the company says the current health hazard of the deviation remains unknown.
Which eye drops were recalled?
The items listed did not reveal the specific brands that sold these products but identified AvKARE as the manufacturer.
“Further use of this product should immediately cease,” AvKARE said in a statement Monday.
The following items, shipped between May 26, 2023 and April 21, 2025, were identified in the recall:
The FDA advises all consumers to check the national drug codes and expiration dates of their products and dispose of them immediately if they match the descriptions.
Specific lot numbers of the affected products can be found on the AvKARE website.
This article originally appeared on Rockland/Westchester Journal News: Eye drop manufacturer AvKARE issues recall on certain products. What to know
Reporting by Alexandra Rivera, Rockland/Westchester Journal News / Rockland/Westchester Journal News
USA TODAY Network via Reuters Connect
